Login to Your Account



Microbiome's influence on checkpoint blockade is confirmed in clinic

By Anette Breindl
Senior Science Editor

Thursday, November 2, 2017

A lot of effort has been expended on understanding what determines the efficacy of checkpoint blockade. Much of that effort has been focused on the tumor and the immune system – reasonably enough, since those are the direct combatants in the tumor-immune face-off.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription